Home / Companies / Daxor Corporation

Daxor Corporation

FDA Regulatory Profile

Daxor Corporation appears in FDA public data with 0 recalls, 4 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on June 18, 2026.

Summary

Total Recalls
0
510(k) Clearances
4
Inspections
4
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K261099Blood Volume Analyzer (200)June 18, 2026
K251087Blood Volume Analyzer (200)August 4, 2025
K970419DAXOR MAX100 SYRINGE (MAX100)December 22, 1997
K964406AUTOMATED MULTI-POINT BLOOD VOLUME ANALYZERSeptember 25, 1997

FDA data resources